<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30272359</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>20</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1791-3004</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>26</Day>                    </PubDate>                </JournalIssue>                <Title>Molecular medicine reports</Title>                <ISOAbbreviation>Mol Med Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2018.9511</ELocationID>            <Abstract>                <AbstractText>Cervical cancer is a serious malignancy that affects the health of females. In the present study, the association between breast cancer type 1 susceptibility protein/breast cancer type 2 susceptibility protein‑containing complex subunit 3 (BRCC3) and cervical cancer was investigated. Reverse transcription‑quantitative polymerase chain reaction and western blotting were performed to determine BRCC3 mRNA and protein expression levels in cervical cancer tissues and cells, in addition to the expression levels of proteins associated with the epithelial‑mesenchymal transition (EMT) process in HeLa and SiHa cells. Cell Counting Kit‑8, Transwell and wound healing assays were performed to determine the cell viability, invasion and migration abilities of cervical cancer cells, respectively. The results of the present study revealed that BRCC3 expression was significantly increased in cervical cancer tissues, which was also revealed to be associated with the clinical stages and pathological grades of cervical cancer exhibited by patients, in addition to the survival time. Furthermore, BRCC3 expression levels were enhanced in HeLa, SiHa and C‑33A cervical cancer cells. BRCC3 interference in HeLa and SiHa cells was revealed to suppress cell viability, invasion and migration abilities via upregulation of E‑cadherin expression levels and downregulation of Vimentin, matrix metalloproteinase (MMP)‑2, MMP‑9, snail family transcriptional repressor (Snai)1 and Snai2 expression levels. In conclusion, the expression levels of BRCC3 were revealed to be increased in cervical cancer tissues, which were positively associated with clinical features of cervical cancer. Furthermore, BRCC3 interference inhibited the cell viability, invasion and migration abilities of HeLa and SiHa cells via regulation of EMT progression and expression levels of Snai family members. In addition, the results of the present study suggested that BRCC3 represents an oncogene associated with cervical cancer, and may also represent a novel therapeutic biomarker for the diagnosis, treatment and prognosis of patients with cervical cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Feifang</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang 321000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhou</LastName>                    <ForeName>Qun</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310018, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>26</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Mol Med Rep</MedlineTA>            <NlmUniqueID>101475259</NlmUniqueID>            <ISSNLinking>1791-2997</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2013 Feb;13(2):97-110</RefSource>                <PMID Version="1">23344542</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 14;8(11):18248-18259</RefSource>                <PMID Version="1">28212558</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gynecol Oncol. 2018 Sep;150(3):406-411</RefSource>                <PMID Version="1">30017539</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FEBS Open Bio. 2016 Mar 10;6(4):326-37</RefSource>                <PMID Version="1">27239445</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer Prev. 2018 Nov;27(6):546-552</RefSource>                <PMID Version="1">28704213</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2004 Mar 1;22(5):872-80</RefSource>                <PMID Version="1">14990643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biochem. 2018 Sep;119(9):7363-7376</RefSource>                <PMID Version="1">29761931</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Dermatol. 2012 Jun;166(6):1184-97</RefSource>                <PMID Version="1">22332917</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2013 Sep;11(9):1078-87</RefSource>                <PMID Version="1">23761168</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>                <PMID Version="1">11846609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Pathol. 2013 Jan;44(1):62-8</RefSource>                <PMID Version="1">22939954</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2012 Apr 14;379(9824):1391-2</RefSource>                <PMID Version="1">22500876</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2003 Nov;12(5):1087-99</RefSource>                <PMID Version="1">14636569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Magn Reson Imaging. 2018 May 14;:null</RefSource>                <PMID Version="1">29761595</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2016 Dec;55(12):1952-1961</RefSource>                <PMID Version="1">26618609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2011 Apr;102(4):815-27</RefSource>                <PMID Version="1">21219539</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2017 Jul;38(1):82-88</RefSource>                <PMID Version="1">28504814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Aug 1;65(15):6543-50</RefSource>                <PMID Version="1">16061633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2013 Jan 24;49(2):331-8</RefSource>                <PMID Version="1">23246432</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2015 Feb;36(2):1067-72</RefSource>                <PMID Version="1">25326810</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2000 Feb;2(2):76-83</RefSource>                <PMID Version="1">10655586</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Health Med. 2018 Dec;23(10):1250-1260</RefSource>                <PMID Version="1">30101600</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med Rep. 2018 Oct;18(4):3751-3759</RefSource>                <PMID Version="1">30106147</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cells Tissues Organs. 2007;185(1-3):191-203</RefSource>                <PMID Version="1">17587825</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2007 Aug 1;121(3):621-32</RefSource>                <PMID Version="1">17405118</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2015 Jan 28;356(2 Pt B):321-31</RefSource>                <PMID Version="1">25281477</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2017 Jul 13;36(28):3964-3975</RefSource>                <PMID Version="1">28288135</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2012 Jan 20;148(1-2):349-61</RefSource>                <PMID Version="1">22265420</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Gynecol Cancer. 2018 Oct;28(8):1576-1583</RefSource>                <PMID Version="1">30095702</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Immunol. 2018 Jun 12;9:1277</RefSource>                <PMID Version="1">29946318</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2018 Nov;53(5):2067-2080</RefSource>                <PMID Version="1">30106127</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Oct 22;378(9801):1461-84</RefSource>                <PMID Version="1">21924486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med Rep. 2018 Oct;18(4):4138-4146</RefSource>                <PMID Version="1">30106105</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1995 Nov 1;55(21):4757-9</RefSource>                <PMID Version="1">7585499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Med. 2007 Jan;19(1):29-39</RefSource>                <PMID Version="1">17143545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2013 May 1;331(2):131-8</RefSource>                <PMID Version="1">23268331</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am Fam Physician. 2018 Apr 1;97(7):449-454</RefSource>                <PMID Version="1">29671552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Einstein (Sao Paulo). 2018;16(3):eAO4190</RefSource>                <PMID Version="1">30110067</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Oct 1;63(19):6537-42</RefSource>                <PMID Version="1">14559848</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiat Oncol. 2015 May 30;10:123</RefSource>                <PMID Version="1">26024915</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Oncol. 2017 Jul;11(7):860-877</RefSource>                <PMID Version="1">28556516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oral Oncol. 2012 Oct;48(10):997-1006</RefSource>                <PMID Version="1">22704062</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2015 Apr 7;313(13):1347-61</RefSource>                <PMID Version="1">25849179</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Trop Med. 2015 Nov;8(11):937-943</RefSource>                <PMID Version="1">26614994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2005 Jul;14(1):89-92</RefSource>                <PMID Version="1">15944773</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Biol. 1991 Apr;113(1):173-85</RefSource>                <PMID Version="1">2007622</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Nov 15;5(21):10901-15</RefSource>                <PMID Version="1">25337721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Magn Reson Imaging. 2018 Aug 13;:null</RefSource>                <PMID Version="1">30102438</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>2</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30272359</ArticleId>            <ArticleId IdType="doi">10.3892/mmr.2018.9511</ArticleId>            <ArticleId IdType="pmc">PMC6236300</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>